Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Multi-center, Double-blind, Randomized, Placebo-controlled Effectiveness and Safety Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

NCT00625404 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.

NCT NCT00625404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00625404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Multi-center, Double-blind, Randomized, Placebo-controlled Effectiveness and Safety Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Lead sponsor
FHI 360
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
January 31, 2013
Enrollment
2,120 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections